NANOSYRINX
NanoSyrinx is an emerging biotechnology company developing a novel system for targeted delivery of therapeutic proteins and peptides direct to the cytosol. We are using synthetic biology approaches to develop a completely novel method for targeted drug delivery of therapeutic proteins and peptides, to the interiors of cells, to improve efficacy, safety, and economy.
NANOSYRINX
Industry:
Biotechnology Medical Therapeutics
Founded:
2018-01-01
Address:
Coventry, Coventry, United Kingdom
Country:
United Kingdom
Website Url:
http://www.nanosyrinx.com
Total Employee:
1+
Status:
Active
Total Funding:
8.47 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Euro Typekit Squarespace
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Vulkam
Vulkam is an innovative microtechnology start up from the french research laboratories.
Current Advisors List
Board_member
2020-09-30
Current Employees Featured
Joe Healey Chief Executive Officer @ NanoSyrinx
Chief Executive Officer
2020-02-01
Founder
Investors List
Octopus Ventures
Octopus Ventures investment in Seed Round - NanoSyrinx
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund investment in Seed Round - NanoSyrinx
Future Planet Capital
Future Planet Capital investment in Seed Round - NanoSyrinx
IQ Capital
IQ Capital investment in Seed Round - NanoSyrinx
M Ventures
M Ventures investment in Seed Round - NanoSyrinx
BioCity Group
BioCity Group investment in Seed Round - NanoSyrinx
Jonathan Milner
Jonathan Milner investment in Seed Round - NanoSyrinx
M Ventures
M Ventures investment in Pre Seed Round - NanoSyrinx
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund investment in Pre Seed Round - NanoSyrinx
Future Planet Capital
Future Planet Capital investment in Pre Seed Round - NanoSyrinx
Official Site Inspections
http://www.nanosyrinx.com Semrush global rank: 6.68 M Semrush visits lastest month: 874
- Host name: server259-35.web-hosting.com
- IP address: 199.188.206.86
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "NanoSyrinx"
Home - NanoSyrinx
NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We …See details»
About - NanoSyrinx
NanoSyrinx is a discovery stage synthetic biology company developing a novel system based …See details»
NanoSyrinx - Crunchbase Company Profile & Funding
View contacts for NanoSyrinx to access new leads and connect with decision-makers. …See details»
Team - NanoSyrinx
Currently Chairman of NanoSyrinx Ltd, Achilles Therapeutics plc, LabGenius Ltd and Avantium …See details»
NanoSyrinx Company Profile 2024: Valuation, Funding …
Developer of a novel biologics drug delivery system intended to serve the biopharmaceutical sector.See details»
Member profile: NanoSyrinx Ltd | BIA - bioindustry.org
NanoSyrinx is a discovery stage synthetic biology company, spun-out of the University of …See details»
NanoSyrinx closes c. £10 million GBP financing and appoints Dr.
Coventry, UK, 10 September 2024: NanoSyrinx, a synthetic biology company developing …See details»
Synthetic Biology start up NanoSyrinx secures capital to develop …
NanoSyrinx is the first company to engineer ‘nanosyringes’, a selective non-viral peptide and …See details»
Warwick spinout NanoSyrinx raises £6.2m funding to …
Jul 19, 2021 · NanoSyrinx is the first company to engineer protein ‘nanosyringes’, a cell-selective non-viral peptide and protein delivery system. Targeted delivery of therapeutics is an important solution to improve efficacy and minimise …See details»
NanoSyrinx - M Ventures
NanoSyrinx is an emerging biotechnology company developing a novel cell engineering system …See details»
NanoSyrinx - VentureRadar
NanoSyrinx is built around an entirely genetically encoded drug delivery system, making use of …See details»
AbbVie and Pioneer Group name NanoSyrinx as the winner of the …
Oct 14, 2022 · NanoSyrinx is the first company to engineer protein ‘nanosyringes’, a cell …See details»
NanoSyrinx: Breaking the dogma of intracellular medicines.
What NanoSyrinx focus on is changing the payload and engineering how the nanosyringes …See details»
Technology - NanoSyrinx
NanoSyrinx is built around an entirely genetically encoded drug delivery system, making use of …See details»
NanoSyrinx Secures $13M Funding to Advance Intracellular Drug …
Sep 11, 2024 · NanoSyrinx, a synthetic biology company focused on developing nanosyringes …See details»
Warwick Medical School spin-out NanoSyrinx secures capital to …
Oct 5, 2020 · NanoSyrinx, an emerging biotechnology company developing new therapeutic …See details»
JPM 2024: NanoSyrinx Wields Original Bacterial Syringe IP for …
Jan 12, 2024 · The NanoSyrinx leadership is looking toward a series A round to build out and …See details»
Newsroom - NanoSyrinx
NanoSyrinx has been named as the winner of the 2022 AbbVie UK Golden Ticket accelerator …See details»
a novel platform technology for drug delivery - Anglonordic Life …
NanoSyrinx proposes a hybrid model: develop in-house programs for currently undruggable …See details»
Nanostructures pave the way for advanced robotics—and mini …
23 hours ago · Velcro DNA. To assemble the voxels, the team incorporate additional DNA …See details»